Monday, 22 Jan 2018

You are here

Kevin Winthrop, MD: H. zoster and tofacitinib: the risk of concomitant nonbiologic therapy

Dr. Kevin Winthrop, associate professor of infectious diseases at Oregon Health & Sciences University in Portland, Oregon, discusses abstract 559.

Add new comment

Want to talk about this video? Comment here to lead the discussion.
ACR VIDEO

Dr. Ted Pincus - FAST3 A Novel...

10 Jul 2017

Dr. Kathryn Dao: Steroid Duration...

06 Nov 2017

The RheumNow Week in Review - 3...

03 Nov 2017

Dr. Olga Petryna: TKR and Role of...

05 Nov 2017

15 September 2017 The RheumNow Week in...

15 Sep 2017

Dr. Dan Furst - the faSSinate study;...

04 Aug 2016

The RheumNow Week in Review – 14 April...

14 Apr 2017

4 Contraindications to TNF Inhibitor Use

03 Oct 2016

The RheumNow Week in Review – 3...

03 Feb 2017

Dr. Patrick Wood: brain calcification...

02 Mar 2016

Dr. Rachel Tate: Exhibit Hall

07 Nov 2017

The RheumNow Week in Review – 7 April...

07 Apr 2017